Table 5.
Details of the treatment of PPDC patients
| Medication | ||
|---|---|---|
| Duration of medication (day) | ||
| All patients | 7 (3–31)a | |
| Severity of PPDC | ||
| Mild | 7 (3–26)a | |
| Moderate | 7 (5–31)a | |
| Medication for PPDC | Number of events | |
| Oral antibiotic treatment | 6 | |
| Intravenous antibiotic treatment | 27 | |
| Intravenous therapy followed by oral antibiotics | 3 | |
| Antibacterial agents | ||
| First antibacterial agent administered | Number of events | |
| Sulbactam / ampicillin | 21 | |
| Ceftriaxone | 5 | |
| Levofloxacin (oral antibiotics) | 6 | |
| Others | 4 | |
| Cases with subsequent change of antibiotics | 11 | |
| Treatment for stenosis of hepaticojejunostomy | Patients (n = 4) | |
|---|---|---|
| Patient no. | Number of events of PPDC | Treatment (severity of PPDC) |
| 1 | 3 | BD + SI (mild), SI (mild), BD + EL, SI (moderate), BD |
| 2 | 2 | BD + SI + EL (moderate), SI + EL (mild) |
| 3 | 5 | SI (moderate) |
| 4 | 3 | EO |
BD Endoscopic baloon dilation; SI Endoscopic stent insertion; EL Endoscopic lithotripsy; EO Endoscopic observation only
aData was presented as median (range)